Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huachao Chen

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Acta Pharmaceutica Sinica. B|July 18, 2022
Cancer-cell-biomimetic nanoparticles systemically eliminate hypoxia tumors by synergistic chemotherapy and checkpoint blockade immunotherapyYongrong Yao, Huachao Chen, Ninghua Tan
Chemical Communications (Cambridge, England)|July 15, 2014
An H₂O₂-responsive nanocarrier for dual-release of platinum anticancer drugs and O₂: controlled release and enhanced cytotoxicity against cisplatin resistant cancer cellsHuachao Chen, Weijiang He, Zijian Guo
Biomaterials Science|June 24, 2020
New strategy for precise cancer therapy: tumor-specific delivery of mitochondria-targeting photodynamic therapy agents and in situ O<sub>2</sub>-generation in hypoxic tumorsHuachao Chen, Chengkun He, Tianyi Chen, et al.
Journal of Materials Chemistry. B|April 8, 2020
Dimeric BODIPY-loaded liposomes for dual hypoxia marker imaging and activatable photodynamic therapy against tumorsHuachao Chen, Qirui Bi, Yongrong Yao, et al.
Biomaterials Science|September 6, 2023
Programmable site-specific delivery of an alkaline phosphatase-activatable prodrug and a mitochondria-targeted cyclopeptide for combination therapy in colon cancerHuachao Chen, Yongrong Yao, Xing Zhao, et al.
Journal of the American Chemical Society|January 10, 2015
H2O2-activatable and O2-evolving nanoparticles for highly efficient and selective photodynamic therapy against hypoxic tumor cellsHuachao Chen, Jiangwei Tian, Weijiang He, et al.
International Journal of Nanomedicine|July 30, 2021
Hyaluronic Acid Coated Liposomes Co-Delivery of Natural Cyclic Peptide RA-XII and Mitochondrial Targeted Photosensitizer for Highly Selective Precise Combined Treatment of Colon CancerYanqing Xu, Yongrong Yao, Linxiao Wang, et al.
Biomaterials Science|November 6, 2019
Programmed delivery of cyclopeptide RA-V and antisense oligonucleotides for combination therapy on hypoxic tumors and for therapeutic self-monitoringYongrong Yao, Li Feng, Zhe Wang, et al.
Journal of Materials Chemistry. B|April 9, 2020
Dual aptamer modified dendrigraft poly-l-lysine nanoparticles for overcoming multi-drug resistance through mitochondrial targetingHuachao Chen, Jiangwei Tian, Danyang Liu, et al.
Acta Biomaterialia|May 27, 2024
A structure-guided strategy to design Golgi apparatus-targeted type-I/II aggregation-induced emission photosensitizers for efficient photodynamic therapyXing Zhao, Xi Wu, Ranran Shang, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Acta Pharmaceutica Sinica. B|July 18, 2022
Cancer-cell-biomimetic nanoparticles systemically eliminate hypoxia tumors by synergistic chemotherapy and checkpoint blockade immunotherapyYongrong Yao, Huachao Chen, Ninghua Tan
Chemical Communications (Cambridge, England)|July 15, 2014
An H₂O₂-responsive nanocarrier for dual-release of platinum anticancer drugs and O₂: controlled release and enhanced cytotoxicity against cisplatin resistant cancer cellsHuachao Chen, Weijiang He, Zijian Guo
Biomaterials Science|June 24, 2020
New strategy for precise cancer therapy: tumor-specific delivery of mitochondria-targeting photodynamic therapy agents and in situ O<sub>2</sub>-generation in hypoxic tumorsHuachao Chen, Chengkun He, Tianyi Chen, et al.
Journal of Materials Chemistry. B|April 8, 2020
Dimeric BODIPY-loaded liposomes for dual hypoxia marker imaging and activatable photodynamic therapy against tumorsHuachao Chen, Qirui Bi, Yongrong Yao, et al.
Biomaterials Science|September 6, 2023
Programmable site-specific delivery of an alkaline phosphatase-activatable prodrug and a mitochondria-targeted cyclopeptide for combination therapy in colon cancerHuachao Chen, Yongrong Yao, Xing Zhao, et al.
Journal of the American Chemical Society|January 10, 2015
H2O2-activatable and O2-evolving nanoparticles for highly efficient and selective photodynamic therapy against hypoxic tumor cellsHuachao Chen, Jiangwei Tian, Weijiang He, et al.
International Journal of Nanomedicine|July 30, 2021
Hyaluronic Acid Coated Liposomes Co-Delivery of Natural Cyclic Peptide RA-XII and Mitochondrial Targeted Photosensitizer for Highly Selective Precise Combined Treatment of Colon CancerYanqing Xu, Yongrong Yao, Linxiao Wang, et al.
Biomaterials Science|November 6, 2019
Programmed delivery of cyclopeptide RA-V and antisense oligonucleotides for combination therapy on hypoxic tumors and for therapeutic self-monitoringYongrong Yao, Li Feng, Zhe Wang, et al.
Journal of Materials Chemistry. B|April 9, 2020
Dual aptamer modified dendrigraft poly-l-lysine nanoparticles for overcoming multi-drug resistance through mitochondrial targetingHuachao Chen, Jiangwei Tian, Danyang Liu, et al.
Acta Biomaterialia|May 27, 2024
A structure-guided strategy to design Golgi apparatus-targeted type-I/II aggregation-induced emission photosensitizers for efficient photodynamic therapyXing Zhao, Xi Wu, Ranran Shang, et al.
Pageof 3